Cofarma Pharmaceuticals Private Limited
About Cofarma Pharmaceuticals Private Limited
Data last updated:
Cofarma Pharmaceuticals Private Limited is a private limited company based in Thalassery, Kerala, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 26 November 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Ernakulam, under CIN U24233KL2007PTC021466. Its GSTIN is 32AAECC4891J1ZJ (Kerala).
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹28 Lakh. It is led by directors Chellath Mohanan (Managing Director) and Koorikkattil Lathika.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Building No.653 Ward No.48 1st Floor City Centre P.O: Thalassery, Kerala, India – 670101.
As per the financials filed for FY 2024, the company reported a revenue of ₹12.67 Lakh, a decline of 43% compared to the previous year. For the same year it recorded a net loss of ₹72,680 (net margin -5.7%) and EBITDA of -₹74,180 (EBITDA margin -5.9%). Revenue has declined at a compounded annual rate (CAGR) of 19% over three years and 15% over five years.
The current compliance status is marked as active non-compliant by the Registrar of Companies.
Company details
Contact details
Cofarma Pharmaceuticals Private Limited's registered office is in Thalassery, Kerala. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressBuilding No.653 Ward No.48 1st Floor City Centre P.O: Thalassery, Kerala, India – 670101
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Cofarma Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Cofarma Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Cofarma Pharmaceuticals Private Limited, buy the company report.
Financials of Cofarma Pharmaceuticals Private Limited
FY 2024 filings availableCofarma Pharmaceuticals Private Limited reported revenue of ₹12.67 Lakh (down 43% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 15% over five years, including a 43% fall in the latest year. EBITDA rose 52% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹74,180 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹72,680 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -5.9% | ||||
| Net Profit Margin | -5.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Cofarma Pharmaceuticals Private Limited, buy the company report.
Board of directors of Cofarma Pharmaceuticals Private Limited
Cofarma Pharmaceuticals has 2 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Koorikkattil Lathika Also directs: Kadathanad Coconut Producer Company Limited | Director | 23 Jan 2024 | 2 Years 9 Months | Current |
| Chellath Mohanan | Managing Director | 23 Jan 2024 | 2 Years 9 Months | Current |
Auditor
Cofarma Pharmaceuticals Private Limited is audited by P MOHAN & ASSOCIATES LLP for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| P MOHAN & ASSOCIATES LLP | FY 2022 | 002105S |
Shareholding
The shareholding of Cofarma Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Cofarma Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Cofarma Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Cofarma Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Cofarma Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 32AAECC4891J1ZJ | Kerala | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Cofarma Pharmaceuticals Private Limited, buy the company report.
Recent activity
Cofarma Pharmaceuticals Private Limited has 9 board changes on record since 2010: 2 appointments and 7 cessations. The latest: Koorikkattil Lathika ceased to be Additional Director on 29 Sep 2024.
Frequently asked questions
Cofarma Pharmaceuticals is an active private limited company based in Thalassery, Kerala, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 26 November 2007 (19+ years old) and is registered under CIN U24233KL2007PTC021466.
Cofarma Pharmaceuticals has 2 current directors:
- Chellath Mohanan - Managing Director
- Koorikkattil Lathika - Director
The latest financial statements of Cofarma Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Cofarma Pharmaceuticals is 32AAECC4891J1ZJ, registered in Kerala.
The CIN (Corporate Identification Number) of Cofarma Pharmaceuticals is U24233KL2007PTC021466. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Cofarma Pharmaceuticals was incorporated on 26 November 2007, making it 19+ years old. It is registered with the Registrar of Companies, Ernakulam.
Koorikkattil Lathika ceased to be Additional Director on 29 Sep 2024. Haridasan Thavath ceased to be Managing Director on 25 May 2024. Kadangot Gopalakrishnan ceased to be Director on 18 May 2024. Cofarma Pharmaceuticals has 9 board changes on record in total.
The registered office of Cofarma Pharmaceuticals is at Building No.653 Ward No.48 1st Floor City Centre P.O: Thalassery, Kerala, India – 670101.
Cofarma Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Cofarma Pharmaceuticals is active non-compliant as of 07 July 2026. The company is actively filing with the Registrar of Companies.